AstraZeneca ( AZN ) announced Monday it had reached agreements to settle approximately 17,500 Seroquel product liability suits in the U.S. for some $198 million. The suits allege that anti-psychotic Seroquel causes weight-gain diabetes in some patients. The agreements in principle are subject to finalization of non-monetary terms, the company added. The company said it made no provisions as of the end... Continue reading AstraZeneca Agrees to Settle Seroquel Claims for $198 Million AstraZeneca Agrees to Settle Seroquel Claims for $198 Million originally appeared on DailyFinance on Mon, 09 Aug 2010 07:52:00. Filed Under: Company News , Astrazeneca , Stocks in the News Permalink | Tweet this! | Comments